53,699 XNAS Volume
XNAS 19 Mar, 2025 3:07 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| David Domzalski | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 730,000 | 730,000 | - | - | Stock Option (right to buy) | |
| Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 230,000 | 230,000 | - | - | Stock Option (right to buy) | |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 230,000 | 230,000 | - | - | Stock Option (right to buy) | |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 230,000 | 230,000 | - | - | Stock Option (right to buy) | |
| Patrick G. LePore | Director | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 15 Jan 2025 | 15,000 | 51,472 (0%) | 0% | 2.9 | 43,800 | Common Stock |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 31 Dec 2024 | 4,675 | 126,892 (0%) | 0% | 3.3 | 15,661 | Common Stock |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 31 Dec 2024 | 4,697 | 144,329 (0%) | 0% | 3.4 | 15,735 | Common Stock |
| Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 31 Dec 2024 | 4,857 | 128,637 (0%) | 0% | 3.4 | 16,271 | Common Stock |
| Domzalski David | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 31 Dec 2024 | 24,536 | 476,061 (1%) | 0% | 3.4 | 82,196 | Common Stock |
| Christine Borowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| G. LePore Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Sharon Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Elisabeth A. Sandoval Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Domzalski David | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 2.10 per share. | 30 Nov 2024 | 3,901 | 500,597 (2%) | 0% | 2.1 | 8,192 | Common Stock |
| David Domzalski | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 30 Sep 2024 | 685 | 496,696 (2%) | 0% | 1.9 | 1,288 | Common Stock |
| Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 30 Sep 2024 | 109 | 133,494 (0%) | 0% | 1.9 | 205 | Common Stock |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 30 Sep 2024 | 105 | 149,026 (0%) | 0% | 1.9 | 197 | Common Stock |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 30 Sep 2024 | 84 | 131,567 (0%) | 0% | 1.9 | 158 | Common Stock |
| David Domzalski | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 01 Jul 2024 | 935 | 497,654 (2%) | 0% | 1.9 | 1,795 | Common Stock |
| Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 01 Jul 2024 | 138 | 133,603 (0%) | 0% | 1.9 | 265 | Common Stock |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 01 Jul 2024 | 143 | 149,131 (0%) | 0% | 1.9 | 275 | Common Stock |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 01 Jul 2024 | 92 | 131,651 (0%) | 0% | 1.9 | 177 | Common Stock |
| David Domzalski | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 2.16 per share. | 31 May 2024 | 4,429 | 498,589 (2%) | 0% | 2.2 | 9,562 | Common Stock |
| David Domzalski | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 01 Apr 2024 | 1,004 | 494,160 (2%) | 0% | 3.1 | 3,092 | Common Stock |
| Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 01 Apr 2024 | 157 | 133,741 (0%) | 0% | 3.1 | 484 | Common Stock |
| Mutya Harsch | CHIEF LEGAL OFFICER AND GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 01 Apr 2024 | 161 | 149,274 (0%) | 0% | 3.1 | 496 | Common Stock |
| Tyler Zeronda | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.09 per share. | 01 Apr 2024 | 94 | 131,743 (0%) | 0% | 3.1 | 290 | Common Stock |
| Borowski Christine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Basta L. Steven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Stuart A. Iain | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.28 per share. | 01 Jan 2024 | 157 | 133,898 (0%) | 0% | 2.3 | 358 | Common Stock |
| Stuart A. Iain | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 134,055 (0%) | 0% | 0 | Common Stock | |
| Zeronda Tyler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Domzalski David | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 225,000 | 496,168 (2%) | 0% | 0 | Common Stock | |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.28 per share. | 01 Jan 2024 | 1,004 | 495,164 (2%) | 0% | 2.3 | 2,289 | Common Stock |
| Tyler Zeronda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 131,930 (0%) | 0% | 0 | Common Stock | |
| Harsch Mutya | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| G. LePore Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Harsch Mutya | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.28 per share. | 01 Jan 2024 | 161 | 149,435 (0%) | 0% | 2.3 | 367 | Common Stock |
| Harsch Mutya | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 149,596 (0%) | 0% | 0 | Common Stock | |
| Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Sandoval-Little A. Elisabeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Iain Stuart A. | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Tyler Zeronda | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.28 per share. | 01 Jan 2024 | 93 | 131,837 (0%) | 0% | 2.3 | 212 | Common Stock |
| Stuart A. Iain | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 71,555 (0%) | 0% | 0 | Common Stock | |
| Tyler Zeronda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 69,430 (0%) | 0% | 0 | Common Stock | |
| G. Patrick LePore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Surrey-Barbari Sharon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| A. Elisabeth Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| L. Steven Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 225,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Stuart Iain A. | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 87,096 (0%) | 0% | 0 | Common Stock | |
| Zeronda Tyler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 225,000 | 271,168 (1%) | 0% | 0 | Common Stock | |
| Domzalski David | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.81 per share. | 30 Nov 2023 | 2,284 | 46,168 (0%) | 0% | 2.8 | 6,426 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 30 Jun 2023 | 981 | 52,433 (0%) | 0% | 4.1 | 4,022 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 30 Jun 2023 | 151 | 10,239 (0%) | 0% | 4.1 | 619 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 30 Jun 2023 | 157 | 25,750 (0%) | 0% | 4.1 | 644 | Common Stock |
| Tyler Zeronda | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 30 Jun 2023 | 91 | 8,017 (0%) | 0% | 4.1 | 373 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.46 per share. | 31 May 2023 | 2,766 | 53,414 (0%) | 0% | 3.5 | 9,560 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 3.46 per share. | 31 May 2023 | 3,664 | 25,907 (0%) | 0% | 3.5 | 12,664 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 31 Mar 2023 | 2,734 | 50,648 (0%) | 0% | 3.1 | 8,421 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 31 Mar 2023 | 480 | 10,390 (0%) | 0% | 3.1 | 1,478 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 31 Mar 2023 | 478 | 22,243 (0%) | 0% | 3.1 | 1,472 | Common Stock |
| Tyler Zeronda | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.08 per share. | 31 Mar 2023 | 384 | 8,108 (0%) | 0% | 3.1 | 1,183 | Common Stock |
| Patrick G. LePore | Director | Purchase of securities on an exchange or from another person at price $ 2.48 per share. | 20 Mar 2023 | 20,000 | 23,472 (0%) | 0% | 2.5 | 49,680 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 20 Mar 2023 | 10,000 | 22,721 (0%) | 0% | 2.5 | 25,000 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 31 Dec 2022 | 10,685 | 1,064,290 (4%) | 0% | 0.2 | 1,603 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 31 Dec 2022 | 1,720 | 220,252 (0%) | 0% | 0.2 | 258 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 31 Dec 2022 | 1,813 | 229,144 (0%) | 0% | 0.2 | 272 | Common Stock |
| Tyler Zeronda | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.15 per share. | 31 Dec 2022 | 354 | 173,005 (0%) | 0% | 0.1 | 53 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.20 per share. | 30 Nov 2022 | 34,705 | 1,074,975 (4%) | 0% | 0.2 | 6,861 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.22 per share. | 30 Sep 2022 | 10,683 | 1,040,270 (4%) | 0% | 0.2 | 2,382 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.22 per share. | 30 Sep 2022 | 1,719 | 221,972 (0%) | 0% | 0.2 | 383 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.22 per share. | 30 Sep 2022 | 1,813 | 230,957 (0%) | 0% | 0.2 | 404 | Common Stock |
| Tyler Zeronda | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.22 per share. | 30 Sep 2022 | 353 | 173,359 (0%) | 0% | 0.2 | 79 | Common Stock |
| Patrick G. LePore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
| Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
| Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
| Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 30 Jun 2022 | 10,683 | 1,050,953 (4%) | 0% | 0.4 | 4,156 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 30 Jun 2022 | 1,719 | 223,691 (0%) | 0% | 0.4 | 669 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 30 Jun 2022 | 1,813 | 232,770 (0%) | 0% | 0.4 | 705 | Common Stock |
| Tyler Zeronda | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. | 30 Jun 2022 | 354 | 173,712 (0%) | 0% | 0.4 | 138 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 31 May 2022 | 11,887 | 1,061,636 (4%) | 0% | 0.3 | 4,116 | Common Stock |
| Tyler Zeronda | CFO | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 31 May 2022 | 12,510 | 174,066 (0%) | 0% | 0.3 | 4,332 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 31 Mar 2022 | 23,186 | 1,049,749 (4%) | 0% | 0.7 | 15,071 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 31 Mar 2022 | 3,469 | 225,410 (0%) | 0% | 0.7 | 2,255 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 31 Mar 2022 | 3,630 | 234,583 (0%) | 0% | 0.7 | 2,360 | Common Stock |
| Tyler Zeronda | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 31 Mar 2022 | 773 | 161,556 (0%) | 0% | 0.6 | 502 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 312,302 | 1,072,935 (4%) | 1% | 0 | Common Stock | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 312,303 | 312,303 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 75,000 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 228,879 (0%) | 0% | 0 | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 75,000 | - | - | Stock Options | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 238,213 (0%) | 0% | 0 | Common Stock | |
| Tyler Zeronda | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 162,329 (0%) | 0% | 0 | Common Stock | |
| Tyler Zeronda | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 75,000 | 75,000 | - | - | Stock Options | |
| Patrick G. LePore | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 30 Nov 2021 | 12,500 | 62,500 (0%) | 0% | 1.0 | 12,699 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 30 Nov 2021 | 4,705 | 767,520 (3%) | 0% | 0.9 | 4,119 | Common Stock |
| Tyler Zeronda | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 30 Nov 2021 | 4,187 | 87,535 (0%) | 0% | 0.9 | 3,666 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 30 Sep 2021 | 13,096 | 762,815 (3%) | 0% | 1.4 | 18,203 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 30 Sep 2021 | 1,480 | 155,129 (0%) | 0% | 1.4 | 2,057 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 30 Sep 2021 | 1,484 | 164,697 (0%) | 0% | 1.4 | 2,063 | Common Stock |
| Tyler Zeronda | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 30 Sep 2021 | 206 | 83,348 (0%) | 0% | 1.4 | 286 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 320,313 | 320,313 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 320,312 | 775,911 (3%) | 1% | 0 | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,860 | 60,860 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,859 | 156,609 (0%) | 0% | 0 | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,860 | 60,860 | - | - | Stock Options | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,859 | 166,181 (0%) | 0% | 0 | Common Stock | |
| Tyler Zeronda | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,859 | 83,554 (0%) | 0% | 0 | Common Stock | |
| Tyler Zeronda | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 60,860 | 60,860 | - | - | Stock Options | |
| Patrick G. LePore | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 25 Aug 2021 | 12,500 | 50,000 (0%) | 0% | 1.6 | 20,000 | Common Stock |
| Patrick G. LePore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options | |
| Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options | |
| Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options | |
| Elisabeth A. Sandoval | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.51 per share. | 30 Jun 2021 | 18,859 | 455,599 (1%) | 0% | 3.5 | 66,195 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.51 per share. | 30 Jun 2021 | 3,083 | 95,750 (0%) | 0% | 3.5 | 10,821 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.51 per share. | 30 Jun 2021 | 3,551 | 105,322 (0%) | 0% | 3.5 | 12,464 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.51 per share. | 30 Jun 2021 | 5,151 | 109,246 (0%) | 0% | 3.5 | 18,080 | Common Stock |
| Tyler Zeronda | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.51 per share. | 30 Jun 2021 | 700 | 22,695 (0%) | 0% | 3.5 | 2,457 | Common Stock |
| Andrew Saik | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.36 per share. | 28 May 2021 | 3,017 | 116,468 (0%) | 0% | 3.4 | 10,130 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.36 per share. | 28 May 2021 | 941 | 474,458 (1%) | 0% | 3.4 | 3,159 | Common Stock |
| Patrick G. LePore | Director | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 26 May 2021 | 12,500 | 37,500 (0%) | 0% | 3.6 | 44,958 | Common Stock |
| Andrew Saik | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 31 Mar 2021 | 762 | 113,451 (0%) | 0% | 6.8 | 5,212 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 31 Mar 2021 | 6,316 | 473,517 (1%) | 0% | 6.8 | 43,201 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 31 Mar 2021 | 1,945 | 98,833 (0%) | 0% | 6.8 | 13,304 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 31 Mar 2021 | 1,765 | 108,873 (0%) | 0% | 6.8 | 12,073 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 31 Mar 2021 | 2,573 | 114,397 (0%) | 0% | 6.8 | 17,599 | Common Stock |
| Patrick G. LePore | Director | Purchase of securities on an exchange or from another person at price $ 7.41 per share. | 15 Mar 2021 | 12,500 | 25,000 (0%) | 0% | 7.4 | 92,563 | Common Stock |
| Andrew Saik | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 29,213 | 114,213 (0%) | 0% | 0 | Common Stock | |
| Andrew Saik | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 68,162 | 68,162 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 358,750 | 358,750 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 153,750 | 479,833 (1%) | 0% | 0 | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 68,162 | 68,162 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 29,213 | 100,778 (0%) | 0% | 0 | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 29,213 | 110,638 (0%) | 0% | 0 | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 68,162 | 68,162 | - | - | Stock Options | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 64,575 | 64,575 | - | - | Stock Options | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 27,675 | 116,970 (0%) | 0% | 0 | Common Stock | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.44 per share. | 30 Nov 2020 | 4,263 | 1,313,990 (5%) | 0% | 1.4 | 6,160 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 1.45 per share. | 30 Nov 2020 | 10,460 | 327,525 (1%) | 0% | 1.4 | 15,115 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 1.45 per share. | 30 Nov 2020 | 7,838 | 358,722 (1%) | 0% | 1.4 | 11,326 | Common Stock |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 30 Sep 2020 | 6,239 | 1,309,727 (5%) | 0% | 1.7 | 10,357 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 30 Sep 2020 | 2,378 | 288,640 (1%) | 0% | 1.7 | 3,947 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 30 Sep 2020 | 1,822 | 317,065 (1%) | 0% | 1.7 | 3,025 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. | 30 Sep 2020 | 1,541 | 350,884 (1%) | 0% | 1.7 | 2,558 | Common Stock |
| Patrick G. LePore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 45,000 | 45,000 | - | - | Stock Options | |
| Andrew Saik | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.46 per share. | 08 Sep 2020 | 40,000 | 340,000 (1%) | 0% | 1.5 | 58,480 | Common Stock |
| David Domzalski | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 08 Sep 2020 | 75,000 | 1,315,966 (5%) | 0% | 1.4 | 103,568 | Common Stock |
| Sharon Surrey-Barbari | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2020 | 75,000 | 13,971 | - | - | Stock Options | |
| Sharon Surrey-Barbari | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.48 per share. | 20 Aug 2020 | 75,000 | 75,000 (0%) | 0% | 1.5 | 111,000 | Common Stock |
| Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 22,500 | 22,500 | - | - | Stock Options | |
| Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 22,500 | 22,500 | - | - | Stock Options | |
| Elisabeth A. Sandoval | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 22,500 | 22,500 | - | - | Stock Options | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 22,500 | 22,500 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.73 per share. | 30 Jun 2020 | 6,239 | 1,240,966 (5%) | 0% | 1.7 | 10,793 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.73 per share. | 30 Jun 2020 | 2,378 | 291,018 (1%) | 0% | 1.7 | 4,114 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.73 per share. | 30 Jun 2020 | 1,822 | 318,887 (1%) | 0% | 1.7 | 3,152 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.73 per share. | 30 Jun 2020 | 1,541 | 352,425 (1%) | 0% | 1.7 | 2,666 | Common Stock |
| Andrew Saik | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 250,000 | 300,000 (1%) | 1% | 0 | Common Stock | |
| Andrew Saik | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 250,000 | 250,000 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 680,000 | 1,247,213 (5%) | 2% | 0 | Common Stock | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 680,000 | 680,000 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 112,500 | 293,401 (1%) | 0% | 0 | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 112,500 | 112,500 | - | - | Stock Options | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 150,000 | 320,712 (1%) | 0% | 0 | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 150,000 | 150,000 | - | - | Stock Options | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 150,000 | 353,967 (1%) | 0% | 0 | Common Stock | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 150,000 | 150,000 | - | - | Stock Options | |
| Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 14,499 | 536,537 (2%) | 0% | - | Common Stock | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 71,303 | 201,410 (0%) | 0% | - | Common Stock | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 220,496 | 328,609 (1%) | 0% | - | Common Stock | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 63,844 | 130,107 (0%) | 0% | - | Common Stock | |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 03 Apr 2020 | 11,772 | 567,213 (2%) | 0% | 1.4 | 16,481 | Common Stock |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 141,901 | 329,397 (1%) | 0% | - | Common Stock | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 249,588 | 578,985 (2%) | 1% | - | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 27,530 | 86,982 (0%) | 0% | - | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 97,682 | 184,664 (0%) | 0% | - | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 03 Apr 2020 | 3,763 | 180,901 (0%) | 0% | 1.4 | 5,268 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 26,381 | 82,884 (0%) | 0% | - | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 92,302 | 175,186 (0%) | 0% | - | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 03 Apr 2020 | 4,474 | 170,712 (0%) | 0% | 1.4 | 6,264 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 03 Apr 2020 | 908 | 203,967 (0%) | 0% | 1.4 | 1,271 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 46,394 | 113,445 (0%) | 0% | - | Common Stock | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2020 | 91,430 | 204,875 (0%) | 0% | - | Common Stock | |
| David Domzalski | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 31 Mar 2020 | 4,456 | 187,496 (0%) | 0% | 2.7 | 11,942 | Common Stock |
| Iain A. Stuart | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 31 Mar 2020 | 1,940 | 59,452 (0%) | 0% | 2.7 | 5,199 | Common Stock |
| Mutya Harsch | Chief Legal Officer and GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 31 Mar 2020 | 1,688 | 56,503 (0%) | 0% | 2.7 | 4,524 | Common Stock |
| Matthew T. Wiley | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 31 Mar 2020 | 525 | 67,051 (0%) | 0% | 2.7 | 1,407 | Common Stock |
| Andrew Saik | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2020 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Andrew Saik | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2020 | 100,000 | 100,000 | - | - | Stock Options | |
| Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 45,000 | 45,000 | - | - | Stock Option | |
| Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 45,000 | 45,000 | - | - | Stock Option | |
| Elisabeth A. Sandoval | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 45,000 | 45,000 | - | - | Stock Option | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 45,000 | 45,000 | - | - | Stock Option | |
| Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 29,271 | 29,271 | - | - | Stock Options | |
| Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 7,108 | 522,038 (2%) | 0% | - | Common Stock | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 48,667 | 48,667 | - | - | Stock Options | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 34,960 | 66,263 (0%) | 0% | - | Common Stock | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 108,113 | 108,113 (0%) | 0% | - | Common Stock | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 31,303 | 31,303 (0%) | 0% | - | Common Stock | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 15,994 | 15,994 | - | - | Stock Options | |
| Stanley Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 29,481 | 29,481 | - | - | Stock Options | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 12,773 | 12,773 | - | - | Stock Options | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 14,778 | 14,778 | - | - | Stock Options | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 29,271 | 29,271 | - | - | Stock Options | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 22,603 | 22,603 | - | - | Stock Options | |
| Rex Bright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 15,994 | 15,994 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 101,296 | 101,296 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 53,850 | 53,850 (0%) | 0% | - | Common Stock | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 138,102 | 191,952 (0%) | 0% | - | Common Stock | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 11,107 | 11,107 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 140,286 | 140,286 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 35,544 | 35,544 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 42,278 | 42,278 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 194,141 | 194,141 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 41,578 | 41,578 | - | - | Stock Options | |
| David Domzalski | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 142,716 | 142,716 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 57,086 | 57,086 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 56,275 | 56,275 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 20,789 | 20,789 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 116,231 | 116,231 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 35,774 | 35,774 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 35,544 | 35,544 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 119,667 | 119,667 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 10,663 | 10,663 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 14,291 | 14,291 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 3,239 | 3,239 | - | - | Stock Options | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 69,012 | 77,351 (0%) | 0% | - | Common Stock | |
| Ilan Hadar | CFO and Country Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 8,339 | 8,339 (0%) | 0% | - | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 17,772 | 17,772 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 23,696 | 23,696 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 54,086 | 61,392 (0%) | 0% | - | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 7,306 | 7,306 (0%) | 0% | - | Common Stock | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 57,086 | 57,086 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 45,020 | 45,020 | - | - | Stock Options | |
| Iain A. Stuart | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 7,701 | 7,701 | - | - | Stock Options | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 50,643 | 58,191 (0%) | 0% | - | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 7,548 | 7,548 (0%) | 0% | - | Common Stock | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 41,643 | 41,643 | - | - | Stock Options | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 29,620 | 29,620 | - | - | Stock Options | |
| Mutya Harsch | Chief Legal Officer and GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 57,086 | 57,086 | - | - | Stock Options | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 57,086 | 57,086 | - | - | Stock Options | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 59,240 | 59,240 | - | - | Stock Options | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 46,680 | 67,576 (0%) | 0% | - | Common Stock | |
| Matthew T. Wiley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 20,896 | 20,896 (0%) | 0% | - | Common Stock | |
| Kristine M. Ball | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 80,300 | 0 | - | - | Restricted Stock Units | |
| Kristine M. Ball | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 80,300 | 80,300 (0%) | 0% | - | Common stock | |
| Kristine M. Ball | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 11 Dec 2019 | 27,766 | 52,534 (0%) | 0% | 4.5 | 125,502 | Common stock |
| Kristine M. Ball | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 80,300 | 80,300 (0%) | 0% | - | Common stock | |
| Kristine M. Ball | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 11 Dec 2019 | 27,766 | 52,534 (0%) | 0% | 4.5 | 125,502 | Common stock |
| Steven L. Basta | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 11 Dec 2019 | 85,210 | 495,764 (2%) | 0% | 4.5 | 385,149 | Common stock |
| Steven L. Basta | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 238,800 | 580,974 (2%) | 0% | - | Common stock | |
| Steven L. Basta | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 14,000 | 357,641 | - | - | Non-Qualified Stock Option | |
| Steven L. Basta | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.83 per share. | 11 Dec 2019 | 14,000 | 509,764 (2%) | 0% | 1.8 | 25,620 | Common stock |
| Steven L. Basta | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 238,800 | 0 | - | - | Restricted Stock Units | |
| Ronald A. Krasnow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 24,090 | 0 | - | - | Restricted Stock Units | |
| Ronald A. Krasnow | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 24,090 | 24,090 (0%) | 0% | - | Common stock | |
| Ronald A. Krasnow | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 11 Dec 2019 | 8,271 | 15,819 (0%) | 0% | 4.5 | 37,385 | Common stock |
| Paul Kwon | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 80,300 | 0 | - | - | Restricted Stock Units | |
| Paul Kwon | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 80,300 | 80,300 (0%) | 0% | - | Common stock | |
| Paul Kwon | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2019 | 80,300 | 80,300 (0%) | 0% | - | Common stock | |
| Paul Kwon | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 11 Dec 2019 | 27,766 | 52,534 (0%) | 0% | 4.5 | 125,502 | Common stock |
| Paul Kwon | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 11 Dec 2019 | 27,766 | 52,534 (0%) | 0% | 4.5 | 125,502 | Common Stock |
| Kristine M. Ball | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2019 | 80,300 | 413,423 | - | - | Restricted Stock Units | |
| Steven L. Basta | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2019 | 238,800 | 1,050,100 | - | - | Restricted Stock Units | |
| Ronald A. Krasnow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2019 | 24,090 | 154,090 | - | - | Restricted Stock Units | |
| Paul Kwon | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2019 | 80,300 | 396,812 | - | - | Restricted Stock Units | |
| David W.J. McGirr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2019 | 22,500 | 65,780 | - | - | Stock Option | |
| Paul L. Berns | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2019 | 22,500 | 65,780 | - | - | Stock Option | |
| Scott M. Whitcup | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2019 | 22,500 | 134,099 | - | - | Stock Option | |
| Elisabeth A. Sandoval | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2019 | 11,645 | 45,000 | - | - | Stock Option | |
| Ted Ebel | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2019 | 22,500 | 53,423 | - | - | Stock Option | |
| Aaron Royston | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2019 | 22,500 | 22,500 | - | - | Stock Option | |
| Ronald A. Krasnow | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 130,000 | 130,000 | - | - | Stock Option | |
| Elisabeth A. Sandoval | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2019 | 33,355 | 33,355 | - | - | Stock Option | |
| Scott M. Whitcup | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2019 | 25,000 | 77,043 | - | - | Stock Option | |
| Kristine M. Ball | SVP, Corporate Strategy & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2018 | 96,000 | 96,000 | - | - | Stock Option | |
| Mary C. Spellman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2018 | 96,000 | 96,000 | - | - | Stock Option | |
| Steven L. Basta | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2018 | 141,900 | 141,900 | - | - | Stock Option | |
| Paul Kwon | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2018 | 64,000 | 64,000 | - | - | Stock Option | |
| Kristine M. Ball | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2018 | 64,000 | 237,123 | - | - | Stock Option | |
| Steven L. Basta | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2018 | 212,850 | 669,400 | - | - | Stock Option | |
| Paul Kwon | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2018 | 64,000 | 252,512 | - | - | Stock Option | |
| Albert Cha | None | 25 Jan 2018 | 126,703 | 486,695 (2%) | 0% | 0 | Common Stock | ||
| Albert Cha | None | 25 Jan 2018 | 6,335,215 | 0 | - | - | Series B Preferred Stock | ||
| Albert Cha | None | 25 Jan 2018 | 874,817 | 0 | - | - | Series B Preferred Stock | ||
| Albert Cha | None | 25 Jan 2018 | 2,475,118 | 0 | - | - | Series C Preferred Stock | ||
| Albert Cha | None | 25 Jan 2018 | 341,784 | 0 | - | - | Series C Preferred Stock | ||
| Albert Cha | None | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 25 Jan 2018 | 258,432 | 258,432 (1%) | 1% | 17 | 4,393,344 | Common Stock |
| Albert Cha | None | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 25 Jan 2018 | 35,686 | 35,686 (0%) | 0% | 17 | 606,662 | Common Stock |
| Albert Cha | None | 25 Jan 2018 | 2,348,550 | 2,606,982 (11%) | 10% | 0 | Common Stock | ||
| Albert Cha | None | 25 Jan 2018 | 324,306 | 359,992 (1%) | 1% | 0 | Common Stock | ||
| Albert Cha | None | 25 Jan 2018 | 917,559 | 3,524,541 (15%) | 3% | 0 | Common Stock |